Citation:Isaksson S, Bogefors K, Ståhl O, Eberhard J, Giwercman YL, Leijonhufvud I, et al 2018

From Cancer Guidelines Wiki

Citation


Isaksson S, Bogefors K, Ståhl O, Eberhard J, Giwercman YL, Leijonhufvud I, et al. High risk of hypogonadism in young male cancer survivors. Clin Endocrinol (Oxf) 2018 Mar;88(3):432-441 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29245176.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Testicular function after cancer treatmentDr Rita Upreti MBChB PhD FRACPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Is the testicular function of male cancer survivors who had cancer treatment, more adversely affected than males in the general population, as measured by markers of their testicular function after treatment?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Is the testicular function of male cancer survivors who had cancer treatment, more adversely affected than males in the general population, as measured by markers of their testicular function after treatment?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Testicular function